[HTML] hindawi.com

[HTML][HTML] Resveratrol Suppresses PAI-1 Gene Expression in a Human In Vitro Model of Inflamed Adipose Tissue

I Zagotta, EY Dimova, JB Funcke, M Wabitsch… - Oxidative medicine and … - hindawi.com
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …
被引用次数：36 相关文章
[PDF] psu.edu

[PDF][PDF] Resveratrol Suppresses PAI-1 Gene Expression in a Human In Vitro Model of Inflamed Adipose Tissue

I Zagotta, EY Dimova, JB Funcke, M Wabitsch… - 2013 - Citeseer
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …
[HTML] hindawi.com

[HTML][HTML] Resveratrol Suppresses PAI-1 Gene Expression in a Human In Vitro Model of Inflamed Adipose Tissue

I Zagotta, EY Dimova, JB Funcke, M Wabitsch… - Oxidative Medicine and … - hindawi.com
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …
[PDF] researchgate.net

[PDF][PDF] Resveratrol Suppresses PAI-1 Gene Expression in a Human In Vitro Model of Inflamed Adipose Tissue

I Zagotta, EY Dimova, JB Funcke, M Wabitsch… - 2013 - researchgate.net
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …

Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue

I Zagotta, EY Dimova, JB Funcke, M Wabitsch… - 2023 - oulurepo.oulu.fi
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …

Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue.

I Zagotta, EY Dimova, JB Funcke… - … Medicine and Cellular …, 2013 - europepmc.org
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …
[HTML] nih.gov

[HTML][HTML] Resveratrol Suppresses PAI-1 Gene Expression in a Human In Vitro Model of Inflamed Adipose Tissue

I Zagotta, EY Dimova, JB Funcke… - … Medicine and Cellular …, 2013 - ncbi.nlm.nih.gov
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …

Resveratrol Suppresses PAI-1 Gene Expression in a HumanIn VitroModel of Inflamed Adipose Tissue

I Zagotta, EY Dimova, JB Funcke, M Wabitsch… - Oxidative Medicine and …, 2013 - cir.nii.ac.jp
抄録< jats: p> Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with
a number of pathophysiological complications; among them is obesity. Resveratrol was …

Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue

I Zagotta, EY Dimova, JB Funcke… - Oxidative medicine …, 2013 - pubmed.ncbi.nlm.nih.gov
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …
[PDF] semanticscholar.org

[PDF][PDF] Resveratrol Suppresses PAI-1 Gene Expression in a Human In Vitro Model of Inflamed Adipose Tissue

I Zagotta, EY Dimova, JB Funcke, M Wabitsch… - 2013 - pdfs.semanticscholar.org
Increased plasminogen activator inhibitor-1 (PAI-1) levels are associated with a number of
pathophysiological complications; among them is obesity. Resveratrol was proposed to …